Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Autoimmune Disorders

  Free Subscription


Articles published in J Rheumatol

Retrieve available abstracts of 226 articles:
HTML format



Single Articles


    June 2021
  1. VILLIGER PM
    Giant Cell Arteritis: Real-life Experience.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210334. doi: 10.3899/jrheum.210334.
    PubMed     Abstract available


    May 2021
  2. HAZLEWOOD GS, Pardo J, Barnabe C, Schieir O, et al
    Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases.
    J Rheumatol. 2021 May 15. pii: jrheum.210288. doi: 10.3899/jrheum.210288.
    PubMed     Abstract available


  3. RAHMAN A
    Why Do Patients With Systemic Lupus Erythematosus Suffer Pain?
    J Rheumatol. 2021 May 1. pii: jrheum.210057. doi: 10.3899/jrheum.210057.
    PubMed     Abstract available


    April 2021
  4. DIAZ T, Dominguez D, Jaeggi E, Knight A, et al
    Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort.
    J Rheumatol. 2021 Apr 1. pii: jrheum.201338. doi: 10.3899/jrheum.201338.
    PubMed     Abstract available


  5. LANGLEBEN D, Berkson L, Chartrand S
    Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
    J Rheumatol. 2021;48:616-617.
    PubMed    


    March 2021
  6. RUSSELL AS
    The Variability of Antinuclear Antibody Testing.
    J Rheumatol. 2021 Mar 15. pii: jrheum.210039. doi: 10.3899/jrheum.210039.
    PubMed     Abstract available


  7. MOHAMMAD AJ, Turkiewicz A, Stamatis P, Turesson C, et al
    Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis - A Population-Based Study.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201131. doi: 10.3899/jrheum.201131.
    PubMed     Abstract available


  8. ROSSIDES M
    Stroke is Different in Systemic Lupus Erythematosus: Implications for Survival and Functionality.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201209. doi: 10.3899/jrheum.201209.
    PubMed     Abstract available


    February 2021
  9. CLEMENT J, Duffau P, Constans J, Schaeverbeke T, et al
    Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients.
    J Rheumatol. 2021 Feb 15. pii: jrheum.200952. doi: 10.3899/jrheum.200952.
    PubMed     Abstract available


  10. VYNCKIER J, Demeestere J, Lambert J
    Black-blood Magnetic Resonance Imaging in Giant Cell Arteritis.
    J Rheumatol. 2021;48:301-302.
    PubMed    


    January 2021
  11. AGARWAL S
    Update on Sweet Syndrome in Eosinophilic Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:151.
    PubMed    


    December 2020
  12. ORLANDI M, Landini N, Bruni C, Colagrande S, et al
    Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200832. doi: 10.3899/jrheum.200832.
    PubMed     Abstract available


  13. GERSTEIN M, Borgia RE, Dominguez D, Feldman BM, et al
    Predicting macrophage activation syndrome (MAS) in childhood-onsetsystemic lupus erythematosus (cSLE) patients at diagnosis.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200292. doi: 10.3899/jrheum.200292.
    PubMed     Abstract available


    November 2020
  14. GEORGE M, Venkatachalam S, Banerjee S, Baker JF, et al
    Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
    J Rheumatol. 2020 Nov 15. pii: jrheum.201017. doi: 10.3899/jrheum.201017.
    PubMed     Abstract available


  15. ROSINA S, Varnier GC, Pistorio A, Pilkington C, et al
    Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200543. doi: 10.3899/jrheum.200543.
    PubMed     Abstract available


  16. BATU ED, Kaya Akca U, Pac Kisaarslan A, Sag E, et al
    The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200871. doi: 10.3899/jrheum.200871.
    PubMed     Abstract available


  17. LAMBERS WM, Westra J, Bootsma H, de Leeuw K, et al
    Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200726. doi: 10.3899/jrheum.200726.
    PubMed     Abstract available


  18. ZHANG B, Chi H, Su Y
    Near Tetraploidy in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1725-1726.
    PubMed    


  19. FAYE AS, Lee KE, Laszkowska M, Kim J, et al
    Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City.
    J Rheumatol. 2020 Nov 1. pii: jrheum.200989. doi: 10.3899/jrheum.200989.
    PubMed     Abstract available


  20. GAMWELL KL, Hommel KA
    Comprehensive Care in Pediatric Rheumatic Diseases: A Multifaceted Challenge.
    J Rheumatol. 2020;47:1603-1605.
    PubMed    


    October 2020
  21. KIM JW, Jung JY, Kim HA, Yang JI, et al
    Lupus Low Disease Activity State achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200802. doi: 10.3899/jrheum.200802.
    PubMed     Abstract available


  22. DOMINGUEZ D, Kamphuis S, Beyene J, Wither J, et al
    Relationship between Genetic Risk and Age of Diagnosis of Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200002. doi: 10.3899/jrheum.200002.
    PubMed     Abstract available


  23. MEHTA P, Sattui SE, van der Geest K, Brouwer E, et al
    Giant cell arteritis and COVID-19: similarities and discriminators, a systematic literature review.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200766. doi: 10.3899/jrheum.200766.
    PubMed     Abstract available


    September 2020
  24. TROUNG L, Pourzand L, Volkmann ER
    Covid-19 in Patients with Connective Tissue Disease-Related Interstitial Lung Disease.
    J Rheumatol. 2020 Sep 15. pii: jrheum.201064. doi: 10.3899/jrheum.201064.
    PubMed     Abstract available


  25. SALAMA AD, Caplin B
    Lupus Nephritis and Chronic Kidney Disease.
    J Rheumatol. 2020;47:1303-1304.
    PubMed    


  26. TSELIOS K, Gladman DD, Taheri C, Su J, et al
    Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200161. doi: 10.3899/jrheum.200161.
    PubMed     Abstract available


  27. TSOI LK, Mok CC, Man BL, Fu YP, et al
    Imaging pattern and outcome of stroke in patients with systemic lupus erythematosus: a case-control study.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200664. doi: 10.3899/jrheum.200664.
    PubMed     Abstract available


    August 2020
  28. HIRAKI LT
    APOL1 Gene - Implications for Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1155-1157.
    PubMed    


    July 2020
  29. ALMAGHLOUTH I, Pullenayegum E, Gladman DD, Urowitz MB, et al
    Propensity Score Methods in Rare Disease. A Demonstration Using Observational Data in Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jul 1. pii: jrheum.200254. doi: 10.3899/jrheum.200254.
    PubMed     Abstract available


  30. MURIMI IB, Lin DH, Kan H, Tierce J, et al
    Health Care Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
    J Rheumatol. 2020 Jul 1. pii: jrheum.191187. doi: 10.3899/jrheum.191187.
    PubMed     Abstract available


    June 2020
  31. QUEVEDO-ABELEDO JC, Sanchez-Perez H, Tejera-Segura B, de Armas-Rillo L, et al
    Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jun 15. pii: jrheum.200435. doi: 10.3899/jrheum.200435.
    PubMed     Abstract available


  32. FAVALLI EG, Agape E, Caporali R
    Are patients with systemic lupus erythematosus at increased risk of severe COVID-19?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200723. doi: 10.3899/jrheum.200723.
    PubMed     Abstract available


  33. PESCHKEN CA
    Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    J Rheumatol. 2020;47:787-790.
    PubMed    


  34. SO H, Mak JWY, Tam LS
    No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200605. doi: 10.3899/jrheum.200605.
    PubMed     Abstract available


  35. STOUSTRUP P, Twilt M, Herlin T
    Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2020;47:793-795.
    PubMed    


    May 2020
  36. STAMATIS P, Turkiewicz A, Englund M, Jonsson G, et al
    Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden.
    J Rheumatol. 2020 May 15. pii: jrheum.200211. doi: 10.3899/jrheum.200211.
    PubMed     Abstract available


  37. CHEN C, Yao B, Yan M, Su K, et al
    The plight of patients with lupus nephritis in Wuhan, China.
    J Rheumatol. 2020 May 8. pii: jrheum.200452. doi: 10.3899/jrheum.200452.
    PubMed     Abstract available


  38. SILVA-DIAZ M, Freire Gonzalez M, Romero TH
    Pulmonary Alveolar Proteinosis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:779-780.
    PubMed    


  39. TURK MA, Hayworth JL, Nevskaya T, Pope JE, et al
    Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis.
    J Rheumatol. 2020 May 1. pii: jrheum.190768. doi: 10.3899/jrheum.190768.
    PubMed     Abstract available


  40. KWAK SG, Par SH, Kim JY
    Incidence and prevalence of juvenile systemic lupus erythematosus in Korea: data from the national health claims database 2017.
    J Rheumatol. 2020 May 1. pii: jrheum.191186. doi: 10.3899/jrheum.191186.
    PubMed     Abstract available


    April 2020
  41. FAVALLI EG, Agape E, Caporali R
    Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis.
    J Rheumatol. 2020 Apr 25. pii: jrheum.200507. doi: 10.3899/jrheum.200507.
    PubMed     Abstract available


  42. ERNSTE FC, Chong C, Crowson CS, Kermani TA, et al
    Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Dermatomyositis and Polymyositis Patients.
    J Rheumatol. 2020 Apr 15. pii: jrheum.191374. doi: 10.3899/jrheum.191374.
    PubMed     Abstract available


  43. TSELIOS K, Gladman DD, Su J, Urowitz MB, et al
    Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?
    J Rheumatol. 2020 Apr 1. pii: jrheum.191064. doi: 10.3899/jrheum.191064.
    PubMed     Abstract available


  44. TAKEUCHI T, Wakasugi N, Makino H
    Long-term safety and effectiveness of tacrolimus in lupus nephritis patients: 5- year interim post-marketing surveillance study in Japan (TRUST).
    J Rheumatol. 2020 Apr 1. pii: jrheum.191008. doi: 10.3899/jrheum.191008.
    PubMed     Abstract available


  45. LIU K, Tomlinson G, Reed AM, Huber AM, et al
    Pilot study of the juvenile dermatomyositis consensus treatment plans: a CARRA Registry study.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190494. doi: 10.3899/jrheum.190494.
    PubMed     Abstract available


  46. UROWITZ MB, Gladman DD, Ibanez D, Su J, et al
    Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190259. doi: 10.3899/jrheum.190259.
    PubMed     Abstract available


    March 2020
  47. CLAIRMAN H, Dover S, Whitney K, Marcuz JA, et al
    Correlation of a Modified Disease Activity Score with the Validated Original Disease Activity Score in Patients with Juvenile Dermatomyositis.
    J Rheumatol. 2020 Mar 15. pii: jrheum.191255. doi: 10.3899/jrheum.191255.
    PubMed     Abstract available


  48. NAIDES SJ, Genzen JR, Abel G, Bashleben C, et al
    Antinuclear Antibodies (ANA) Testing Method Variability: A Survey of Participants in the College of American Pathologists' (CAP) Proficiency Testing Program.
    J Rheumatol. 2020 Mar 15. pii: jrheum.190933. doi: 10.3899/jrheum.190933.
    PubMed     Abstract available


  49. HOGE C, Bowling CB, Lim SS, Drenkard C, et al
    Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Mar 1. pii: jrheum.190991. doi: 10.3899/jrheum.190991.
    PubMed     Abstract available


    February 2020
  50. MOISEEV S, Zykova A, Bulanov N, Gitel E, et al
    Is There a Role for LAMP-2 Autoantibodies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis?
    J Rheumatol. 2020 Feb 15. pii: jrheum.191082. doi: 10.3899/jrheum.191082.
    PubMed     Abstract available


  51. WARD JM, Hess JN, Davis LS
    Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
    J Rheumatol. 2020;47:298-299.
    PubMed    


  52. CHANG JC, Knight AM, Lawson EF
    Patterns of Health Care Utilization and Medication Adherence Among Youth with Systemic Lupus Erythematosus During Transfer from Pediatric to Adult Care.
    J Rheumatol. 2020 Feb 1. pii: jrheum.191029. doi: 10.3899/jrheum.191029.
    PubMed     Abstract available


    January 2020
  53. CANNON L, Dvergsten J, Stingl C
    Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review.
    J Rheumatol. 2020 Jan 15. pii: jrheum.190929. doi: 10.3899/jrheum.190929.
    PubMed     Abstract available


    December 2019
  54. MOORE S, Juo HH, Nielsen CT, Tyden H, et al
    Neutrophil extracellular traps identify patients at risk of increased disease activity and cardiovascular comorbidity in systemic lupus erythematosus.
    J Rheumatol. 2019 Dec 15. pii: jrheum.190875. doi: 10.3899/jrheum.190875.
    PubMed     Abstract available


  55. BEN-SHABAT N, Tiosano S, Shovman O, Comaneshter D, et al
    Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study.
    J Rheumatol. 2019 Dec 15. pii: jrheum.190927. doi: 10.3899/jrheum.190927.
    PubMed     Abstract available


  56. CHUA MHY, Ng IAT, Cheung MWL, Mak A, et al
    Association Between Cigarette Smoking and Systemic Lupus Erythematosus - an Updated Multivariate Bayesian Metaanalysis.
    J Rheumatol. 2019 Dec 1. pii: jrheum.190733. doi: 10.3899/jrheum.190733.
    PubMed     Abstract available


  57. DAHAL LN, Barker RN, Ward FJ
    The Soluble Isoform of CTLA-4 Correlates with Interferon-alpha Activity in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Dec 1. pii: jrheum.190678. doi: 10.3899/jrheum.190678.
    PubMed     Abstract available


    November 2019
  58. VAJGEL G, Lima SC, Santana DJS, Oliveira CBL, et al
    A single APOL1 nephropathy variant increases risk of advanced lupus nephritis in Brazilians.
    J Rheumatol. 2019 Nov 15. pii: jrheum.190684. doi: 10.3899/jrheum.190684.
    PubMed     Abstract available


  59. CHEN SK, Barbhaiya M, Solomon DH, Guan H, et al
    Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Nov 1. pii: jrheum.190502. doi: 10.3899/jrheum.190502.
    PubMed     Abstract available


  60. MORONI L, Restovic G, Cervera R, Espinosa G, et al
    Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms.
    J Rheumatol. 2019 Nov 1. pii: jrheum.190533. doi: 10.3899/jrheum.190533.
    PubMed     Abstract available



  61. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:1548.
    PubMed    


    October 2019
  62. COUTURE P, Bachmeyer C, Monfort JB
    Koebner Phenomenon in Dermatomyositis after Subcutaneous Methotrexate Injections.
    J Rheumatol. 2019;46:1350.
    PubMed    


  63. MORAND EF, Golder V
    Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More Is Less?
    J Rheumatol. 2019;46:1256-1258.
    PubMed    


    September 2019
  64. RUACHO G, Kvarnstrom M, Zickert A, Oke V, et al
    Sjogren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250.
    PubMed     Abstract available


  65. SMITH V, Distler O, Cutolo M
    Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?
    J Rheumatol. 2019;46:1061-1063.
    PubMed    


  66. MUKWIKWI ER, Pineau CA, Vinet E, Clarke AE, et al
    Retinal Complications in Systemic Lupus Erythematosus Patients Treated with Antimalarial Drugs.
    J Rheumatol. 2019 Sep 1. pii: jrheum.181102. doi: 10.3899/jrheum.181102.
    PubMed     Abstract available


  67. SMITHERMAN EA, Huang B, Furnier A, Taylor J, et al
    Quality of care in childhood-onset systemic lupus erythematosus: Report of an intervention to improve cardiovascular and bone health screening.
    J Rheumatol. 2019 Sep 1. pii: jrheum.190295. doi: 10.3899/jrheum.190295.
    PubMed     Abstract available


    August 2019
  68. KISHI T, Chipman J, Evereklian M, Nghiem K, et al
    Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
    J Rheumatol. 2019 Aug 1. pii: jrheum.181275. doi: 10.3899/jrheum.181275.
    PubMed     Abstract available


    July 2019
  69. BREKKE LK, Fevang BS, Diamantopoulos AP, Assmus J, et al
    Risk of cancer in 767 patients with giant cell arteritis in western Norway: a retrospective cohort with matched controls.
    J Rheumatol. 2019 Jul 15. pii: jrheum.190147. doi: 10.3899/jrheum.190147.
    PubMed     Abstract available


  70. DE LUCA G, Campochiaro C, Dagna L
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy.
    J Rheumatol. 2019 Jul 1. pii: jrheum.190078. doi: 10.3899/jrheum.190078.
    PubMed     Abstract available


  71. LI C, Zhao J, Zhao Y
    Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:755-756.
    PubMed    


    June 2019
  72. STOJAN G, Magder LS, Petri M
    Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181131. doi: 10.3899/jrheum.181131.
    PubMed     Abstract available


  73. WONG PC, Lee G, Sedie AD, Hanova P, et al
    Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181087. doi: 10.3899/jrheum.181087.
    PubMed     Abstract available


  74. LI YC, Chang DM, Lu CC
    Montreal Cognitive Assessment and Magnetic Resonance Imaging Identify Cognitive Impairment in Young Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:653.
    PubMed    


  75. STAMATIS P, Turesson C, Willim M, Nilsson JA, et al
    Malignancies In Giant Cell Arteritis: A Population-Based Cohort Study.
    J Rheumatol. 2019 Jun 1. pii: jrheum.190236. doi: 10.3899/jrheum.190236.
    PubMed     Abstract available


    May 2019
  76. FELDMAN CH, Malspeis S, Leatherwood C, Kubzansky L, et al
    Association of Childhood Abuse with Incident Systemic Lupus Erythematosus in Adulthood in a Longitudinal Cohort of Women.
    J Rheumatol. 2019 May 15. pii: jrheum.190009. doi: 10.3899/jrheum.190009.
    PubMed     Abstract available


  77. FUJISAWA T, Hozumi H, Yasui H, Suzuki Y, et al
    Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2019 May 15. pii: jrheum.180825. doi: 10.3899/jrheum.180825.
    PubMed     Abstract available


  78. BRUSCHI M, Bonanni A, Petretto A, Vaglio A, et al
    Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis.
    J Rheumatol. 2019 May 15. pii: jrheum.181232. doi: 10.3899/jrheum.181232.
    PubMed     Abstract available


  79. ORMSETH MJ, Solus JF, Sheng Q, Ye F, et al
    Development and Validation of a microRNA Panel to Differentiate between Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus and Controls.
    J Rheumatol. 2019 May 15. pii: jrheum.181029. doi: 10.3899/jrheum.181029.
    PubMed     Abstract available


  80. BROUWER E, VAN DER Geest KSM, Sandovici M
    Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed.
    J Rheumatol. 2019;46:453-454.
    PubMed    


    April 2019
  81. LEGGE A, Kirkland S, Rockwood K, Andreou P, et al
    Construction of a frailty index as a novel health measure in systemic lupus erythematosus.
    J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338.
    PubMed     Abstract available


  82. RUA-FIGUEROA I, Lopez-Longo F, Del Campo V, Galindo-Izquierdo M, et al
    Bacteremia in systemic lupus erythematosus patients from RELESSER: risk factors, clinical and microbiological characteristics and outcomes.
    J Rheumatol. 2019 Apr 15. pii: jrheum.180882. doi: 10.3899/jrheum.180882.
    PubMed     Abstract available


  83. MILLS BS, Dao KH, Tecson KM, Fishman E, et al
    Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network (PLAN) Registry.
    J Rheumatol. 2019 Apr 1. pii: jrheum.181067. doi: 10.3899/jrheum.181067.
    PubMed     Abstract available


  84. BESSE MC, Collercandy N, Diot E
    Gynecologic Vasculitis: Positron Emission Tomography-Computed Tomography Contribution in a Rare Localization of Giant Cell Arteritis.
    J Rheumatol. 2019;46:439.
    PubMed    


  85. BUTENDIECK RR JR, Abril A, Cortese C
    Dr. Butendieck, et al, reply.
    J Rheumatol. 2019;46:439-440.
    PubMed    


  86. SANDHU VK, Weisman MH
    Hydroxychloroquine - How Much Is Too Much?
    J Rheumatol. 2019;46:340-342.
    PubMed    


    March 2019
  87. WITCZAK BN, Hetlevik SO, Sanner H, Barth Z, et al
    Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180526. doi: 10.3899/jrheum.180526.
    PubMed     Abstract available


  88. LI C, Yap DYH, Chan G, Wen YB, et al
    Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy showing Thrombotic Microangiopathy.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180773. doi: 10.3899/jrheum.180773.
    PubMed     Abstract available


  89. DUMONT A, Parienti JJ, Delmas C, Boutemy J, et al
    Factors Associated with Relapse and Dependence to Glucocorticoids in Giant-Cell Arteritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181127. doi: 10.3899/jrheum.181127.
    PubMed     Abstract available


  90. TERRE A, Talbot A, Louvrier C, Picque JB, et al
    Monoclonal gammopathy, arthralgias, and recurrent fever syndrome: a new autoinflammatory syndrome?
    J Rheumatol. 2019 Mar 15. pii: jrheum.181204. doi: 10.3899/jrheum.181204.
    PubMed     Abstract available


  91. BANERJEE S, Quinn KA, Gribbons KB, Rosenblum JS, et al
    Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-Vessel Vasculitis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181222. doi: 10.3899/jrheum.181222.
    PubMed     Abstract available


  92. TAMAI H, Nishina N, Takeuchi T
    Pulmonary Vein Vasculitis Presenting as Multiple Pulmonary Nodules in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:323-324.
    PubMed    


  93. SHA SJ, Hou JH, Xie GT, Sun W, et al
    Improvement of outcomes in patients with lupus nephritis: management evolution in Chinese patients from 1994 to 2010.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180145. doi: 10.3899/jrheum.180145.
    PubMed     Abstract available


  94. UGARTE-GIL MF, Wojdyla D, Pons-Estel GJ, Quintana R, et al
    Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a multi-ethnic, multinational Latin-American Lupus Cohort.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180433. doi: 10.3899/jrheum.180433.
    PubMed     Abstract available


  95. SOLOMON IH, Docken WP, Padera RF
    Giant cell arteritis is not associated with varicella zoster virus in temporal artery biopsies or ascending aortic resections.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180912. doi: 10.3899/jrheum.180912.
    PubMed     Abstract available


    February 2019
  96. TAO JJ, Hiraki LT, Levy DM, Silverman ED, et al
    Comparison of Sensitivities of American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria in Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 15. pii: jrheum.180337. doi: 10.3899/jrheum.180337.
    PubMed     Abstract available


  97. OTOBO TM, Conaghan PG, Maksymowych WP, van der Heijde D, et al
    Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis MRI Score (OMERACT JAMRIS-SIJ).
    J Rheumatol. 2019 Feb 15. pii: jrheum.181115. doi: 10.3899/jrheum.181115.
    PubMed     Abstract available


  98. BARBACKI A, Petri M, Avina-Zubieta A, Alarcon GS, et al
    Fatigue Measurements in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180831. doi: 10.3899/jrheum.180831.
    PubMed     Abstract available


  99. UROWITZ MB, Su J, Gladman DD
    Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180986. doi: 10.3899/jrheum.180986.
    PubMed     Abstract available


  100. LIU LH, Fevrier HB, Goldfien R, Hemmerling A, et al
    Understanding Non-Adherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180946. doi: 10.3899/jrheum.180946.
    PubMed     Abstract available


  101. BEUKELMAN T, Nigrovic PA
    Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone?
    J Rheumatol. 2019;46:124-126.
    PubMed    


    January 2019
  102. MERAYO-CHALICO J, Barrera-Vargas A, Morales-Padilla S, Reyna-De la Garza R, et al
    Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180292. doi: 10.3899/jrheum.180292.
    PubMed     Abstract available


  103. WIRESTAM L, Enocsson H, Skogh T, Padyukov L, et al
    Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180713. doi: 10.3899/jrheum.180713.
    PubMed     Abstract available


  104. QUEVEDO-ABELEDO JC, Rua-Figueroa I, Sanchez-Perez H, Tejera-Segura B, et al
    Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180881. doi: 10.3899/jrheum.180881.
    PubMed     Abstract available


  105. KOSTER MJ, Yeruva K, Crowson CS, Muratore F, et al
    Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180429. doi: 10.3899/jrheum.180429.
    PubMed     Abstract available


  106. BREKKE LK, Fevang BT, Myklebust G
    Increased Incidence of Giant Cell Arteritis in Urban Areas?
    J Rheumatol. 2019 Jan 15. pii: jrheum.180714. doi: 10.3899/jrheum.180714.
    PubMed     Abstract available


  107. HOZUMI H, Fujisawa T, Nakashima R, Yasui H, et al
    Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180778. doi: 10.3899/jrheum.180778.
    PubMed     Abstract available


  108. ZHANG S, Zhang F, Li Y
    Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?
    J Rheumatol. 2019;46:114-116.
    PubMed    


  109. ZOHOURY N
    N. Zohoury replies.
    J Rheumatol. 2019;46:116-117.
    PubMed    


  110. ZHAO Y, Rascoff NE, Iyer RS, Thapa M, et al
    Dr. Zhao, et al, reply.
    J Rheumatol. 2019;46:113-114.
    PubMed    


  111. ROTH J
    Predictive Value of Musculoskeletal Ultrasound for Flares in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2019;46:113.
    PubMed    


    December 2018
  112. JOHNSON SR, Khanna D, Daikh D, Cervera R, et al
    Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
    J Rheumatol. 2018 Dec 15. pii: jrheum.180478. doi: 10.3899/jrheum.180478.
    PubMed     Abstract available


  113. VAN ROON AM, Huisman CC, van Roon AM, Zhang D, et al
    Abnormal Nailfold Capillaroscopy Is Common in Patients with Connective Tissue Disease and Associated with Abnormal Pulmonary Function Tests.
    J Rheumatol. 2018 Dec 15. pii: jrheum.180615. doi: 10.3899/jrheum.180615.
    PubMed     Abstract available


  114. HAGEN M, Englbrecht M, Haschka J, Reiser M, et al
    Cost-effective Tapering Algorithm in Rheumatoid Arthritis Patients: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.
    J Rheumatol. 2018 Dec 1. pii: jrheum.180028. doi: 10.3899/jrheum.180028.
    PubMed     Abstract available


  115. SUN YS, Huang DF, Lin FC, Hsu CK, et al
    Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid.
    J Rheumatol. 2018 Dec 1. pii: jrheum.180104. doi: 10.3899/jrheum.180104.
    PubMed     Abstract available



  116. The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial.
    J Rheumatol. 2018;45:1713.
    PubMed    


  117. GREMESE E, DE Lorenzis E, Ferraccioli GF
    Statins and Mortality in Connective Tissue Diseases: Should We Resume the Cardio-rheumatology Spirit in Our Clinics?
    J Rheumatol. 2018;45:1617-1619.
    PubMed    


    November 2018
  118. MAESHIMA K, Ishii K, Shibata H
    An Adult Fatal Case with a STAT1 Gain-of-function Mutation Associated with Multiple Autoimmune Diseases.
    J Rheumatol. 2018 Nov 15. pii: jrheum.180210. doi: 10.3899/jrheum.180210.
    PubMed     Abstract available


  119. PRADSGAARD DO, Horlyck A, Spannow AH, Heuck C, et al
    A Comparison of Radiographic Joint Space Width Measurements Versus Ultrasonographic Assessment of Cartilage Thickness in Children with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Nov 15. pii: jrheum.170571. doi: 10.3899/jrheum.170571.
    PubMed     Abstract available


  120. UGOLINI R, Muratore F, Salvarani C
    Cardiac and Pulmonary Artery Involvement Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-vessel Giant Cell Arteritis.
    J Rheumatol. 2018;45:1603-1604.
    PubMed    


    October 2018
  121. TSELIOS K, Deeb M, Gladman DD, Harvey P, et al
    Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
    J Rheumatol. 2018 Oct 15. pii: jrheum.180124. doi: 10.3899/jrheum.180124.
    PubMed     Abstract available


  122. YAMADA S, Nagafuchi Y, Fujio K
    Retro-odontoid Pseudotumor Associated with Sjogren Syndrome and Systemic Lupus Erythematosus Serology.
    J Rheumatol. 2018;45:1424-1425.
    PubMed    


  123. YAP DYH, Tang C, Chan GCW, Kwan LPY, et al
    Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.
    J Rheumatol. 2018 Oct 1. pii: jrheum.180507. doi: 10.3899/jrheum.180507.
    PubMed     Abstract available


    September 2018
  124. PESCHKEN CA, Wang Y, Abrahamowicz M, Pope J, et al
    Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Sep 15. pii: jrheum.171454. doi: 10.3899/jrheum.171454.
    PubMed     Abstract available


  125. VAN DELFT MAM, van Beest S, Kloppenburg M, Trouw LA, et al
    Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation.
    J Rheumatol. 2018 Sep 15. pii: jrheum.180256. doi: 10.3899/jrheum.180256.
    PubMed     Abstract available


  126. FAGUER S, Belliere J, Ribes D
    Complement C5-blocking Agent in Refractory Dermatomyositis.
    J Rheumatol. 2018 Sep 15. pii: jrheum.180060. doi: 10.3899/jrheum.180060.
    PubMed     Abstract available


  127. JORGE AM, Lu N, Keller SF, Rai SK, et al
    The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171389. doi: 10.3899/jrheum.171389.
    PubMed     Abstract available


  128. GARG S, Tsagaris K, Cozmuta R, Lipson A, et al
    Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171377. doi: 10.3899/jrheum.171377.
    PubMed     Abstract available


  129. KEELING SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, et al
    Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171459. doi: 10.3899/jrheum.171459.
    PubMed     Abstract available


  130. MITANDER A, Fei Y, Trysberg E, Mohammad M, et al
    Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171325. doi: 10.3899/jrheum.171325.
    PubMed     Abstract available


    August 2018
  131. KEELING SO, Vandermeer B, Medina J, Chatterley T, et al
    Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Aug 15. pii: jrheum.171310. doi: 10.3899/jrheum.171310.
    PubMed     Abstract available


  132. VAN DIJKHUIZEN EHP, Vanoni F, Magnano GM, Magnaguagno F, et al
    Effect of the Inclusion of the Metacarpophalangeal Joints on the Wrist Magnetic Resonance Imaging Scoring System in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Aug 15. pii: jrheum.171246. doi: 10.3899/jrheum.171246.
    PubMed     Abstract available


  133. HETLEVIK SO, Flato B, Aalokken TM, Lund MB, et al
    Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease.
    J Rheumatol. 2018 Aug 1. pii: jrheum.180019. doi: 10.3899/jrheum.180019.
    PubMed     Abstract available


  134. LIPHAUS BL, Sallum AEM, Aikawa NE, Kiss MHB, et al
    Increased Soluble Cytoplasmic Bcl-2 Protein Serum Levels and Expression and Decreased Fas Expression in Lymphocytes and Monocytes in Juvenile Dermatomyositis.
    J Rheumatol. 2018 Aug 1. pii: jrheum.171248. doi: 10.3899/jrheum.171248.
    PubMed     Abstract available


  135. TSELIOS K, Gladman DD, Harvey P, Akhtari S, et al
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
    J Rheumatol. 2018 Aug 1. pii: jrheum.171436. doi: 10.3899/jrheum.171436.
    PubMed     Abstract available


  136. KEELING SO, Bissonauth A, Bernatsky S, Vandermeer B, et al
    Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
    J Rheumatol. 2018 Aug 1. pii: jrheum.171307. doi: 10.3899/jrheum.171307.
    PubMed     Abstract available


  137. BUTENDIECK RR JR, Abril A, Cortese C
    Unusual Presentation of Giant Cell Arteritis in 2 Patients: Uterine Involvement.
    J Rheumatol. 2018;45:1201-1202.
    PubMed    


    July 2018
  138. GARNIER C, Ribes D, Chauveau D, Huart A, et al
    Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    J Rheumatol. 2018 Jul 15. pii: jrheum.180310. doi: 10.3899/jrheum.180310.
    PubMed     Abstract available


  139. YUE C, Su J, Gao R, Wen Y, et al
    Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus-associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170811. doi: 10.3899/jrheum.170811.
    PubMed     Abstract available


  140. ZAMPELI E, Kalogirou EM, Piperi E, Mavragani CP, et al
    Tongue Atrophy in Sjogren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands?
    J Rheumatol. 2018 Jul 15. pii: jrheum.180101. doi: 10.3899/jrheum.180101.
    PubMed     Abstract available


  141. CANTI V, Del Rosso S, Tonello M, Luciano R, et al
    Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170751. doi: 10.3899/jrheum.170751.
    PubMed     Abstract available


  142. BATU ED, Kosukcu C, Taskiran E, Sahin S, et al
    Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171358. doi: 10.3899/jrheum.171358.
    PubMed     Abstract available


  143. MCDONALD EG, Bissonette L, Ensworth S, Dayan N, et al
    Monitoring of Systemic Lupus Erythematosus Pregnancies: A Systematic Literature Review.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171023. doi: 10.3899/jrheum.171023.
    PubMed     Abstract available


  144. EUDY AM, Siega-Riz AM, Engel SM, Franceschini N, et al
    Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171066. doi: 10.3899/jrheum.171066.
    PubMed     Abstract available


  145. ALHARBI S, Ahmad Z, Bookman AA, Touma Z, et al
    Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170953. doi: 10.3899/jrheum.170953.
    PubMed     Abstract available


  146. HUSSEIN S, Suitner M, Beland-Bonenfant S, Baril-Dionne A, et al
    Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: A Systematic Review and Metaanalysis.
    J Rheumatol. 2018 Jul 1. pii: jrheum.170837. doi: 10.3899/jrheum.170837.
    PubMed     Abstract available


  147. SCHAFER VS, Chrysidis S, Dejaco C, Duftner C, et al
    Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises.
    J Rheumatol. 2018 Jul 1. pii: jrheum.171428. doi: 10.3899/jrheum.171428.
    PubMed     Abstract available


  148. BAICUS C
    At What Age Was Systemic Lupus Erythematosus Diagnosed in This Cohort?
    J Rheumatol. 2018;45:1070.
    PubMed    


    June 2018
  149. XIE L, Xu J
    Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171290. doi: 10.3899/jrheum.171290.
    PubMed     Abstract available


  150. TROLDBORG A, Thiel S, Trendelenburg M, Friebus-Kardash J, et al
    The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171033. doi: 10.3899/jrheum.171033.
    PubMed     Abstract available


  151. ZAMPELI E, Skopouli FN, Moutsopoulos HM
    Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome.
    J Rheumatol. 2018;45:877-878.
    PubMed    


  152. FONGAUFIER C, Guffroy A, Lutz JC
    Tongue and Scalp Necrosis: Simultaneous Initial Complications Revealing Giant Cell Arteritis.
    J Rheumatol. 2018;45:873-874.
    PubMed    


  153. LABRADOR-HORRILLO M, Selva-O'Callaghan A
    Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
    J Rheumatol. 2018;45:731-732.
    PubMed    


  154. TSELIOS K, Gladman DD, Touma Z, Su J, et al
    Monophasic Disease Course in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 1. pii: jrheum.171319. doi: 10.3899/jrheum.171319.
    PubMed     Abstract available


  155. GUDERUD K, Maehlen MT, Nordang GBN, Viken MK, et al
    Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis.
    J Rheumatol. 2018 Jun 1. pii: jrheum.170769. doi: 10.3899/jrheum.170769.
    PubMed     Abstract available


    April 2018
  156. RAISSI TC, Hewson C, Pope JE
    Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?
    J Rheumatol. 2018 Apr 15. pii: jrheum.161365. doi: 10.3899/jrheum.161365.
    PubMed     Abstract available


  157. NANGIT A, Lin C, Ishimori ML, Spiegel BMR, et al
    Causes and Predictors of Early Hospital Readmission in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170176. doi: 10.3899/jrheum.170176.
    PubMed     Abstract available


  158. TANHA N, Hansen RB, Nielsen CT, Faurschou M, et al
    Clinical and Serological Associations with the Development of Incident Proteinuria in Danish Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170933. doi: 10.3899/jrheum.170933.
    PubMed     Abstract available


  159. KAWASUMI H, Katsumata Y, Nishino A, Hirahara S, et al
    Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170997. doi: 10.3899/jrheum.170997.
    PubMed     Abstract available


  160. VEGA-MORALES D, Hernandez-Galarza IJ, Galarza-Delgado DA
    Causes of Hospital Mortality in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus in a University Hospital: 1998-2015 Analysis.
    J Rheumatol. 2018;45:583-584.
    PubMed    


  161. ZHAO Y, Rascoff NE, Iyer RS, Thapa M, et al
    Flares of Disease in Children with Clinically Inactive Juvenile Idiopathic Arthritis Were Not Correlated with Ultrasound Findings.
    J Rheumatol. 2018 Apr 1. pii: jrheum.170681. doi: 10.3899/jrheum.170681.
    PubMed     Abstract available


    March 2018
  162. ROMERO-DIAZ J, Acosta-Hernandez RI, Criales-Vera S, Kimura-Hayama E, et al
    Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170330. doi: 10.3899/jrheum.170330.
    PubMed     Abstract available


  163. YANG J, Yang X, Yang J, Li M, et al
    Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170737. doi: 10.3899/jrheum.170737.
    PubMed     Abstract available


  164. LIOZON E, de Boysson H, Dalmay F, Gondran G, et al
    Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170455. doi: 10.3899/jrheum.170455.
    PubMed     Abstract available


  165. FRITZLER MJ, Choi MY, Mahler M
    The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies.
    J Rheumatol. 2018;45:444-445.
    PubMed    


  166. BHANSING KJ, VAN Rosmalen MH, VAN Engelen BG, VAN Riel PL, et al
    Ultrasound: A Potential Tool for Detecting of Fasciitis in Dermatomyositis and Polymyositis.
    J Rheumatol. 2018;45:441-442.
    PubMed    


  167. TIDWELL WJ, Callen JP
    Koebner Phenomenon in Juvenile Dermatomyositis.
    J Rheumatol. 2018;45:437.
    PubMed    


  168. DAVIDSON JE, Fu Q, Ji B, Rao S, et al
    Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
    J Rheumatol. 2018 Mar 1. pii: jrheum.161554. doi: 10.3899/jrheum.161554.
    PubMed     Abstract available


    February 2018
  169. YUE C, Li G, Wen Y, Li X, et al
    Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170561. doi: 10.3899/jrheum.170561.
    PubMed     Abstract available


  170. CAI F, Han F, Wang H, Han H, et al
    The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170553. doi: 10.3899/jrheum.170553.
    PubMed     Abstract available


  171. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170590. doi: 10.3899/jrheum.170590.
    PubMed     Abstract available


  172. CHEN H, Peng Q, Yang H, Yin L, et al
    Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170544. doi: 10.3899/jrheum.170544.
    PubMed     Abstract available


  173. ALEXANDERSON H, Regardt M, Ottosson C, Alemo Munters L, et al
    Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.
    J Rheumatol. 2018 Feb 1. pii: jrheum.161183. doi: 10.3899/jrheum.161183.
    PubMed     Abstract available


  174. LUCAS S, Chang WL, Merien F
    Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.
    J Rheumatol. 2018;45:289-291.
    PubMed    


  175. CHEN YH, Lu CC, Chen HC
    Candida albicans Pyomyositis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2018;45:286-287.
    PubMed    


    January 2018
  176. BERNATSKY S, Ramsey-Goldman R, Petri M, Urowitz MB, et al
    Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jan 15. pii: jrheum.170652. doi: 10.3899/jrheum.170652.
    PubMed     Abstract available


    December 2017
  177. YEUNG Y, Barra LJ
    Cardiovascular Risk Prevention in a Canadian Population of Patients with Giant Cell Arteritis.
    J Rheumatol. 2017;44:1942-1943.
    PubMed    


  178. NAVRATIL M, Ivkovic Jurekovic I
    Chloroquine Toxicity Misdiagnosed as Fabry Disease Associated with Systemic Lupus Erythematosus and Hashimoto Thyroiditis.
    J Rheumatol. 2017;44:1940.
    PubMed    


  179. BLOCKMANS D
    Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis.
    J Rheumatol. 2017;44:1763-1764.
    PubMed    


    November 2017
  180. PAKCHOTANON R, Gladman DD, Su J, Urowitz MB, et al
    More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170645. doi: 10.3899/jrheum.170645.
    PubMed     Abstract available


  181. RICHTER JG, Muth T, Li J, Brinks R, et al
    Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170233. doi: 10.3899/jrheum.170233.
    PubMed     Abstract available


  182. CHEN HL, Shen LJ, Hsu PN, Shen CY, et al
    Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study.
    J Rheumatol. 2017 Nov 15. pii: jrheum.160214. doi: 10.3899/jrheum.160214.
    PubMed     Abstract available


  183. TSELIOS K, Gladman DD, Su J, Ace O, et al
    Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
    J Rheumatol. 2017 Nov 1. pii: jrheum.161121. doi: 10.3899/jrheum.161121.
    PubMed     Abstract available


    October 2017
  184. VITIELLO G, Cammelli D
    Large-vessel Involvement and Varicella Zoster Virus Vasculopathy in Giant Cell Arteritis-related Stroke: Something to Keep an Eye On.
    J Rheumatol. 2017;44:1566.
    PubMed    


  185. CHEN Y, Liu J
    What is the Definition of the Anticytoplasmic Autoantibody?
    J Rheumatol. 2017;44:1564.
    PubMed    


    September 2017
  186. ROSSIDES M, Simard JF, Svenungsson E, von Euler M, et al
    Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170241. doi: 10.3899/jrheum.170241.
    PubMed     Abstract available


  187. CLIFFORD AH, Murphy EM, Burrell SC, Bligh MP, et al
    Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170138. doi: 10.3899/jrheum.170138.
    PubMed     Abstract available


  188. BONEPARTH A, Radhakrishna SM, Greenbaum LA, Yen E, et al
    Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170502. doi: 10.3899/jrheum.170502.
    PubMed     Abstract available



  189. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017;44:1417.
    PubMed    


  190. KUMTHEKAR A, Danve A, Deodhar A
    Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2017;44:1416-1417.
    PubMed    


  191. NANTES SG, Su J, Dhaliwal A, Colosimo K, et al
    Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 1. pii: jrheum.161125. doi: 10.3899/jrheum.161125.
    PubMed     Abstract available


  192. ZOHOURY N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, et al
    Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
    J Rheumatol. 2017 Sep 1. pii: jrheum.170044. doi: 10.3899/jrheum.170044.
    PubMed     Abstract available


    August 2017
  193. BERNATSKY S, Clarke AE, Niaki OZ, Labrecque J, et al
    Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Aug 1. pii: jrheum.170179. doi: 10.3899/jrheum.170179.
    PubMed     Abstract available


    July 2017
  194. CHEN Z, Wang Y, Kuwana M, Xu X, et al
    HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170165. doi: 10.3899/jrheum.170165.
    PubMed     Abstract available


  195. HOZUMI H, Fujisawa T, Enomoto N, Nakashima R, et al
    Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170373. doi: 10.3899/jrheum.170373.
    PubMed     Abstract available


  196. NAGASHIMA T, Iwamoto M, Minota S
    Gottron Sign with Ulceration Is Not a Poor Prognostic Factor in Patients with Dermatomyositis and Interstitial Lung Disease.
    J Rheumatol. 2017;44:1099-1100.
    PubMed    


  197. YAP DYH, Tang C, Ma MKM, Mok MMY, et al
    Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
    J Rheumatol. 2017 Jul 1. pii: jrheum.170226. doi: 10.3899/jrheum.170226.
    PubMed     Abstract available


    June 2017
  198. BRUNNER HI, Bennett MR, Gulati G, Abulaban K, et al
    Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
    J Rheumatol. 2017 Jun 15. pii: jrheum.161128. doi: 10.3899/jrheum.161128.
    PubMed     Abstract available


  199. GU K, Gladman DD, Su J, Urowitz MB, et al
    Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
    J Rheumatol. 2017 Jun 15. pii: jrheum.170072. doi: 10.3899/jrheum.170072.
    PubMed     Abstract available


  200. KURTZMAN DJB, Weinblatt M, Vleugels RA
    Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
    J Rheumatol. 2017;44:850-851.
    PubMed    


  201. TARABORELLI M, Reggia R, Dall'Ara F, Fredi M, et al
    Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.
    J Rheumatol. 2017 Jun 1. pii: jrheum.161364. doi: 10.3899/jrheum.161364.
    PubMed     Abstract available


  202. HEMKE R, Tzaribachev N, Nusman CM, van Rossum MAJ, et al
    Magnetic Resonance Imaging (MRI) of the Knee as an Outcome Measure in Juvenile Idiopathic Arthritis: An OMERACT Reliability Study on MRI Scales.
    J Rheumatol. 2017 Jun 1. pii: jrheum.160821. doi: 10.3899/jrheum.160821.
    PubMed     Abstract available


    May 2017
  203. QUARTUCCIO L, Baldini C, Priori R, Bartoloni E, et al
    Cryoglobulinemia in Sjogren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
    J Rheumatol. 2017 May 15. pii: jrheum.161465. doi: 10.3899/jrheum.161465.
    PubMed     Abstract available


  204. FASANO S, Pierro L, Pantano I, Iudici M, et al
    Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 May 15. pii: jrheum.161351. doi: 10.3899/jrheum.161351.
    PubMed     Abstract available


  205. NAKABO S, Yoshifuji H, Hashimoto M, Imura Y, et al
    Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
    J Rheumatol. 2017 May 15. pii: jrheum.161432. doi: 10.3899/jrheum.161432.
    PubMed     Abstract available


  206. SHI J, Li S, Yang H, Zhang Y, et al
    Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    J Rheumatol. 2017 May 1. pii: jrheum.161480. doi: 10.3899/jrheum.161480.
    PubMed     Abstract available


  207. LE PENDU C, Meignin V, Gonzalez-Chiappe S, Hij A, et al
    Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis.
    J Rheumatol. 2017 May 1. pii: jrheum.170061. doi: 10.3899/jrheum.170061.
    PubMed     Abstract available


  208. KOSTER MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, et al
    Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2017 May 1. pii: jrheum.161516. doi: 10.3899/jrheum.161516.
    PubMed     Abstract available


  209. MURO Y, Iwata N, Tanaka Y, Kodera M, et al
    Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis.
    J Rheumatol. 2017;44:711-712.
    PubMed    


  210. GENEST G, Laskin CA
    Safety and Efficacy of in Vitro Fertilization in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    J Rheumatol. 2017;44:547-549.
    PubMed    


    April 2017
  211. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Apr 15. pii: jrheum.161202. doi: 10.3899/jrheum.161202.
    PubMed     Abstract available


  212. SIMONINI G, Bracaglia C, Cattalini M, Taddio A, et al
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336.
    PubMed     Abstract available


  213. BERNTSEN KS, Tollisen A, Schwartz T, Kirkhus E, et al
    Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
    J Rheumatol. 2017 Apr 1. pii: jrheum.160997. doi: 10.3899/jrheum.160997.
    PubMed     Abstract available


  214. GUERRA F, Gelardi C, Capucci A, Gabrielli A, et al
    Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161311. doi: 10.3899/jrheum.161311.
    PubMed     Abstract available


  215. YANG N, Bhattacharyya S, Weinblatt M
    Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus-associated Hypophysitis.
    J Rheumatol. 2017;44:541-542.
    PubMed    


  216. NIHTYANOVA SI, Denton CP
    Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time.
    J Rheumatol. 2017;44:404-406.
    PubMed    


    March 2017
  217. ZISMAN D, Gladman DD, Stoll ML, Strand V, et al
    The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
    J Rheumatol. 2017;44:342-351.
    PubMed     Abstract available


  218. HORTON DB, Onel KB, Beukelman T, Ringold S, et al
    Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    J Rheumatol. 2017;44:352-360.
    PubMed     Abstract available


  219. WARD TM, Beebe DW, Chen ML, Landis CA, et al
    Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2017;44:361-367.
    PubMed     Abstract available


  220. VAN DAALEN EE, Rahmattulla C, Wolterbeek R, Bruijn JA, et al
    Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
    J Rheumatol. 2017;44:314-318.
    PubMed     Abstract available


  221. AESCHLIMANN FA, Angst F, Hofer KD, Cannizzaro Schneider E, et al
    Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study.
    J Rheumatol. 2017;44:334-341.
    PubMed     Abstract available


  222. STOUSTRUP P, Twilt M, Spiegel L, Kristensen KD, et al
    Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.
    J Rheumatol. 2017;44:326-333.
    PubMed     Abstract available


    February 2017
  223. GUZMAN J, Henrey A, Loughin T, Berard RA, et al
    Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
    J Rheumatol. 2017;44:230-240.
    PubMed     Abstract available


  224. FURUTA S, Chaudhry AN, Arimura Y, Dobashi H, et al
    Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts.
    J Rheumatol. 2017;44:216-222.
    PubMed     Abstract available


    January 2017
  225. THOMAS G, Cohen Aubart F, Chiche L, Haroche J, et al
    Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.
    J Rheumatol. 2017;44:24-32.
    PubMed     Abstract available


    June 2016
  226. NUSMAN CM, Rosendahl K, Maas M
    MRI Protocol for the Assessment of Juvenile Idiopathic Arthritis of the Wrist: Recommendations from the OMERACT MRI in JIA Working Group and Health-e-Child.
    J Rheumatol. 2016;43:1257-8.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: